The dsRed+ leukemia cells express the MLL-AF9 fusion gene and we have successfully used these cells previously in screens as they have a well-defined LSC population and initiate AML with short latency, enabling rapid follow-up experiments in syngeneic hosts.12, 13, 14, 15. This evidence concerns the gene KMT2A and leukemia.